While not disclosing a specific launch timeframe, with de novo clearance in hand, J&J initially plans to launch Ottava with “select customers”.

Health technology brand Hilo, developed by Aktiia, has launched its Hilo Core blood pressure monitoring system in the US.

Under the deal, Personalis’ minimal residual disease (MRD) test will be integrated into Tempus’ broader oncology portfolio.

Following TYBR’s B3 GEL’s US launch in January 2026, the company primarily intends to use the funds to expand market access to the hydrogel.

Cardinal Health’s acquisitions of Strive Medical and Adapt Health’s diabetes unit are collectively intended to support its at-home care business’s growth strategy.

The funds will support the construction of a new manufacturing facility and make significant upgrades to Otsuka ICU Medical's existing manufacturing site in Austin, Texas.

Fresenius Medical Care has introduced TherapyWise, a cloud-based analytics platform aimed at supporting hospital and critical care teams overseeing KRT in the US.

GE HealthCare's tool is intended to streamline imaging workflow collaboration between different specialist teams in areas such as oncology.

Neko Health has raised $700m, setting the company up with proceeds to scale its full-body scanning service ahead of the planned launch of its first US clinics this year. Putting its funds raised to ...

British Business Bank has previously co-invested in EQT's fund portfolio companies Phagenesis and Cyted Health.

GE HealthCare and Catholic Health have signed a 10-year strategic alliance valued at around $500m, aimed at expanding access to precision diagnostics, advanced imaging, and AI-supported technology ...

RapidPulse has secured $48m to advance the clinical development of its aspiration technology to treat acute ischaemic stroke.